Elanco 동물 건강 법인
MX ˙ BMV ˙ US28414H1032
SecurityMX:ELAN / Elanco Animal Health Incorporated
InstitutionVanguard Group Inc
Latest Disclosed Ownership0 shares
Ownership 0.00%
Vanguard Group Inc ownership in ELAN / Elanco Animal Health Incorporated

2026-03-26 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Elanco Animal Health Incorporated (MX:ELAN). This represents 0.0 percent ownership of the company. In their previous filing dated 2024-02-13 , Vanguard Group Inc had reported owning 49,468,637 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-03-26 2026-03-26 13G/A 49,468,637 0 -100.00 0.00 -100.00
2024-02-13 2024-02-13 13G/A 49,307,638 49,468,637 0.33 10.04 0.30
2023-09-11 2023-09-11 13G/A 45,691,838 49,307,638 7.91 10.01 3.84
2023-02-09 2023-02-09 13G/A 40,801,815 45,691,838 11.98 9.64 11.83
2022-02-09 2022-02-09 13G/A 41,732,063 40,801,815 -2.23 8.62 -2.49
2021-02-10 2021-02-10 13G/A 34,077,726 41,732,063 22.46 8.84 -3.18
2020-02-11 2020-02-11 13G 34,077,726 9.13

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 48,059,731 -526,977 -1.08 1,087,592 11.14 0.0158
2025-11-07 2025-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 48,586,708 759,623 1.59 978,536 43.28 0.0146
2025-08-11 2025-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 47,827,085 -496,161 -1.03 682,971 34.60 0.0111
2025-05-09 2025-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 48,323,246 -437,731 -0.90 507,394 -14.07 0.0092
2025-02-11 2024-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 48,760,977 -184,506 -0.38 590,495 -17.87 0.0103
2024-11-13 2024-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 48,945,483 -502,330 -1.02 719,009 0.77 0.0129
2024-08-13 2024-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 49,447,813 189,573 0.38 713,532 -11.02 0.0137
2024-05-10 2024-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 49,258,240 -210,397 -0.43 801,924 8.80 0.0159
2024-03-11 2023-12-31 13F/A-1 ELANCO ANIMAL HEALTH COM 28414H103 49,468,637 467,196 0.95 737,083 33.83 0.0161
2024-02-14 2023-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 49,468,637 467,196 737,083 0.0140
2023-12-18 2023-09-30 13F/A-1 ELANCO ANIMAL HEALTH COM 28414H103 49,001,441 362,152 0.74 550,776 12.56 0.0135
2023-11-14 2023-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 49,001,441 362,152 550,776 0.0024
2023-08-14 2023-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 48,639,289 2,314,726 5.00 489,311 12.37 0.0116
2023-07-14 2023-03-31 13F/A-1 ELANCO ANIMAL HEALTH COM 28414H103 46,324,563 632,725 1.38 435,451 -22.01 0.0111
2023-05-15 2023-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 46,324,563 632,725 435,451 0.0111
2023-02-10 2022-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 45,691,838 3,015,401 7.07 558,354 5.43 0.0152
2022-11-14 2022-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 42,676,437 200,259 0.47 529,614 -36.48 0.0156
2022-08-12 2022-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 42,476,178 1,023,648 2.47 833,807 -22.90 0.0234
2022-05-13 2022-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 41,452,530 650,715 1.59 1,081,496 -6.60 0.0256
2022-02-14 2021-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 40,801,815 -58,573 -0.14 1,157,955 -11.13 0.0263
2021-11-12 2021-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 40,860,388 -1,658,702 -3.90 1,303,039 -11.66 0.0324
2021-08-13 2021-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 42,519,090 372,791 0.88 1,474,989 18.83 0.0367
2021-05-14 2021-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 42,146,299 414,237 0.99 1,241,209 -3.02 0.0336
2021-02-12 2020-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 41,732,062 2,217,632 5.61 1,279,922 15.97 0.0371
2020-11-16 2020-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 39,514,430 2,389,161 6.44 1,103,638 38.59 0.0365
2020-08-14 2020-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 37,125,269 -846,657 -2.23 796,336 -6.33 0.0282
2020-05-15 2020-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 37,971,926 3,894,200 11.43 850,191 -15.28 0.0362
2020-02-14 2019-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 34,077,726 243,817 0.72 1,003,589 11.55 0.0342
2019-11-14 2019-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 33,833,909 1,891,646 5.92 899,643 -16.67 0.0334
2019-08-14 2019-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 31,942,263 2,955,748 10.20 1,079,649 16.14 0.0406
2019-05-15 2019-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 28,986,515 22,735,630 363.72 929,598 371.66 0.0365
2019-02-14 2018-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 6,250,885 1,201,238 23.79 197,090 11.87 0.0089
2018-12-13 2018-09-30 13F/A-2 ELANCO ANIMAL HEALTH COM 28414H103 5,049,647 5,049,647 176,182 0.0069
2018-11-23 2018-09-30 13F/A-1 ELANCO ANIMAL HEALTH COM 28414H103 5,049,647 0 176,182 0.0069
2018-11-14 2018-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 5,049,647 176,182 0.0069
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.